RAIA DROGASIL SA SPON ADR EACH (RADLY) Financials
RADLY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 20.1 billion | 14.1 billion |
| 2023-09-30 | 19.4 billion | 13.6 billion |
| 2023-06-30 | 17.7 billion | 12.1 billion |
| 2023-03-31 | 18.2 billion | 12.7 billion |
RADLY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -546.6 million | 9.9 million |
| 2023-09-30 | -260.2 million | 10.9 million |
| 2023-06-30 | 297.3 million | 9.8 million |
| 2023-03-31 | 167.4 million | 2.6 million |
RADLY Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 390.7 million |
| 2023-09-30 | 301.6 million |
| 2023-06-30 | 416.4 million |
| 2023-03-31 | 203.5 million |
RADLY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 412.3 million | - | 3.9 billion |
| 2023-09-30 | 619.5 million | - | 3.9 billion |
| 2023-06-30 | 370.4 million | - | 3.9 billion |
| 2023-03-31 | 372.3 million | - | 3.7 billion |
RADLY Shares Outstanding
RADLY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 398.6 million | - | 416.9 million | 1.8 billion |
| 2023-09-30 | 349.1 million | - | 388.1 million | 1.7 billion |
| 2023-06-30 | 316.2 million | - | 366.8 million | 1.6 billion |
| 2023-03-31 | 240.7 million | - | 331.8 million | 1.6 billion |
RADLY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 8.9 billion | 6.2 billion |
| 2023-09-30 | 8.7 billion | 6.1 billion |
| 2023-06-30 | 8.4 billion | 5.8 billion |
| 2023-03-31 | 7.9 billion | 5.6 billion |
RADLY
Price: $5
Dividend Yield: 0.04%
Forward Dividend Yield: 1.36%
Payout Ratio: 56.58%
Dividend Per Share: 0.07 USD
Earnings Per Share: 0.12 USD
P/E Ratio: 40.85
Exchange: PNK
Sector: Healthcare
Industry: Pharmaceutical Retailers
Market Capitalization: 10.1 billion
Average Dividend Frequency: 5
Years Paying Dividends: 9
DGR3: 30.00%
DGR5: 18.44%